CREB inhibitor

CAS No. 1433286-70-4

CREB inhibitor ( CREB inhibitor )

Catalog No. M20071 CAS No. 1433286-70-4

666-15 is a potent and selective CREB inhibitor (IC50: 81 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 102 In Stock
10MG 160 In Stock
25MG 327 In Stock
50MG 520 In Stock
100MG 750 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CREB inhibitor
  • Note
    Research use only not for human use.
  • Brief Description
    666-15 is a potent and selective CREB inhibitor (IC50: 81 nM).
  • Description
    666-15 is a potent and selective CREB inhibitor (IC50: 81 nM).
  • Synonyms
    CREB inhibitor
  • Pathway
    Chromatin/Epigenetic
  • Target
    Epigenetic Reader Domain
  • Recptor
    CREB
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1433286-70-4
  • Formula Weight
    620.52
  • Molecular Formula
    C33H31Cl2N3O5
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 60 mg/mL (96.7 mM)
  • SMILES
    Cl.NCCCOc1cc2ccccc2cc1C(=O)NCCOc1cc2ccccc2cc1C(=O)Nc1ccc(Cl)cc1O
  • Chemical Name
    3-(3-Aminopropoxy)-N-[2-[[3-[[(4-chloro-2-hydroxyphenyl)amino]carbonyl]-2-naphthalenyl]oxy]ethyl]-2-naphthalenecarboxamide hydrochloride

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Xie F et al. Identification of a Potent Inhibitor of CREB-Mediated Gene Transcription with Efficacious in Vivo Anticancer Activity. J Med Chem. 2015 Jun 25;58(12):5075-87.
molnova catalog
related products
  • Menin-MLL inhibitor ...

    Menin-MLL inhibitor 20 is an irreversible menin-MLL interaction inhibitor with antitumor activities (WO2020142557A1, compound 6).

  • GSK046

    GSK046 is a potent, selective and orally active BD2 bromodomain inhibitor of the BET proteins(IC50s of 264 nM (BRD2 BD2), 98 nM (BRD3 BD2), 49 nM (BRD4 BD2) and 214 nM (BRDT BD2), respectively).

  • PNZ5

    PNZ5 is a potent and isoxazole-based pan-BET inhibitor, with high selectivity and potency similar to the well-established (+)-JQ1.